Bleakley Financial Group LLC Increases Stake in Cigna Group $CI

Bleakley Financial Group LLC raised its position in Cigna Group (NYSE:CI) by 34.5% during the fourth quarter, HoldingsChannel reports. The firm owned 13,570 shares of the health services provider’s stock after purchasing an additional 3,481 shares during the period. Bleakley Financial Group LLC’s holdings in Cigna Group were worth $3,735,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its holdings in shares of Cigna Group by 1.6% during the 4th quarter. Vanguard Group Inc. now owns 26,173,577 shares of the health services provider’s stock worth $7,203,754,000 after acquiring an additional 414,834 shares during the period. Massachusetts Financial Services Co. MA raised its holdings in shares of Cigna Group by 8.3% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 11,805,083 shares of the health services provider’s stock worth $3,249,113,000 after acquiring an additional 903,334 shares during the period. Dodge & Cox raised its holdings in shares of Cigna Group by 4.0% during the 3rd quarter. Dodge & Cox now owns 9,305,225 shares of the health services provider’s stock worth $2,682,231,000 after acquiring an additional 354,615 shares during the period. Sanders Capital LLC raised its holdings in shares of Cigna Group by 0.5% during the 3rd quarter. Sanders Capital LLC now owns 7,828,168 shares of the health services provider’s stock worth $2,256,469,000 after acquiring an additional 35,150 shares during the period. Finally, Capital Research Global Investors raised its holdings in shares of Cigna Group by 140.2% during the 3rd quarter. Capital Research Global Investors now owns 3,179,301 shares of the health services provider’s stock worth $916,434,000 after acquiring an additional 1,855,897 shares during the period. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Insider Buying and Selling at Cigna Group

In other news, insider Everett Neville sold 1,719 shares of the business’s stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $496,636.29. Following the completion of the transaction, the insider directly owned 5,670 shares of the company’s stock, valued at approximately $1,638,119.70. The trade was a 23.26% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Nicole S. Jones sold 2,307 shares of the business’s stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $666,515.37. Following the transaction, the insider directly owned 32,647 shares of the company’s stock, valued at approximately $9,432,044.77. This represents a 6.60% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 205,904 shares of company stock valued at $60,277,068 in the last three months. 0.60% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several research analysts have recently commented on the company. Leerink Partners lifted their price target on Cigna Group from $270.00 to $297.00 and gave the stock a “market perform” rating in a report on Friday, February 6th. The Goldman Sachs Group lifted their price target on Cigna Group from $335.00 to $340.00 and gave the stock a “buy” rating in a report on Monday, May 4th. Morgan Stanley lifted their price target on Cigna Group from $355.00 to $361.00 and gave the stock an “overweight” rating in a report on Wednesday, May 20th. Cantor Fitzgerald lifted their price target on Cigna Group from $325.00 to $340.00 and gave the stock an “overweight” rating in a report on Friday, May 1st. Finally, Truist Financial lifted their price target on Cigna Group from $320.00 to $350.00 and gave the stock a “buy” rating in a report on Tuesday, February 17th. One analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat, Cigna Group currently has a consensus rating of “Moderate Buy” and a consensus target price of $339.50.

Cigna Group Stock Performance

NYSE CI opened at $281.23 on Wednesday. The company has a market cap of $74.39 billion, a P/E ratio of 11.92, a P/E/G ratio of 1.03 and a beta of 0.30. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.73. The stock has a 50-day moving average of $277.30 and a two-hundred day moving average of $276.52. Cigna Group has a 1-year low of $239.51 and a 1-year high of $338.89.

Cigna Group (NYSE:CI) last released its earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, beating the consensus estimate of $7.60 by $0.19. The company had revenue of $68.52 billion during the quarter, compared to the consensus estimate of $66.29 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.Cigna Group’s revenue was up 4.6% compared to the same quarter last year. During the same period in the previous year, the company posted $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, analysts anticipate that Cigna Group will post 30.39 EPS for the current year.

Cigna Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th will be given a $1.56 dividend. This represents a $6.24 annualized dividend and a yield of 2.2%. The ex-dividend date of this dividend is Thursday, June 4th. Cigna Group’s payout ratio is currently 26.45%.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.